Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CHICAGO and NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- R1, the leader in healthcare revenue management, and Heidi, the leading AI-powered care partner, today announced a strategic partnership....
-
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to...
-
Dextall began façade installation at 38 East 35th Street in Midtown Manhattan, deploying New York City’s first full-scale prefabricated bullnose extrusion.
-
Nashville, Tenn., March 10, 2026 (GLOBE NEWSWIRE) -- Today, Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic...
-
March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled...
-
MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported...
-
Quarterly training programs designed to expand instructor capacity and provide agencies with direct access to Wrap’s integrated NLR training and technology
-
BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on...
-
BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanning immunomodulator, ADC and mRNA candidatesBioNTech co-founders Ugur Sahin and Özlem Türeci will...
-
Healthcare connectivity provider Cellhub launches its “Hospitals Without Walls” program at HIMSS to help hospitals affordably deploy viritual care.